Literature DB >> 4172476

[A simple method for the evaluation of the survival curve in terminal diseases].

H Kaufmann.   

Abstract

Mesh:

Year:  1966        PMID: 4172476

Source DB:  PubMed          Journal:  Strahlentherapie        ISSN: 0039-2073


× No keyword cloud information.
  7 in total

1.  Comparative studies on the physiological ecology of five euryhaline Gammarus species.

Authors:  H P Bulnheim
Journal:  Oecologia       Date:  1979-12       Impact factor: 3.225

2.  [Statistical contributions concerning the grading of gliomas. 3. Astrocytomas and oligodendrogliomas].

Authors:  R Schröder; W Müller; G Bonis; M Vorreith
Journal:  Acta Neurochir (Wien)       Date:  1970       Impact factor: 2.216

3.  Life expectancy of patients with inoperable carcinoma.

Authors:  H van Elmendorff
Journal:  Z Krebsforsch       Date:  1968

4.  [Relations between chromosomal findings and prognosis in acute nonlymphoblastic leukemia (author's transl)].

Authors:  D K Hossfeld; M T Faltermeier; E Wendehorst
Journal:  Blut       Date:  1979-05

5.  [Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. II. Long-term results of a study with 140 patients with retroperitoneal disease (stage II) (author's transl)].

Authors:  M E Scheulen; W Bierbaum; N Niederle; H U Eickenberg; H Holfeld; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1980-08-15

6.  [Delay of operation and survival of cancer patients].

Authors:  H von Elmendorff; H J Heyers; W Neugebauer
Journal:  Langenbecks Arch Chir       Date:  1971

7.  [Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. I. Results of a prospective randomized phase III-study with 71 patients with disseminated disease (stage IV) (author's transl)].

Authors:  M E Scheulen; M Higi; R B Schilcher; C R Meier; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1980-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.